Vlashi Erina, McBride William H, Pajonk Frank
Division of Molecular and Cellular Oncology, Department of Radiation Oncology, David Geffen School of Medicine at UCLA, Los Angeles, California 90095-1714, USA.
J Cell Biochem. 2009 Oct 1;108(2):339-42. doi: 10.1002/jcb.22275.
Recent experimental evidence indicates that many solid cancers have a hierarchical organization structure with a subpopulation of cancer stem cells (CSCs). The ability to identify CSCs prospectively now allows for testing the responses of CSCs to treatment modalities like radiation therapy. Initial studies have found CSCs in glioma and breast cancer relatively resistant to ionizing radiation and possible mechanisms behind this resistance have been explored. This review summarizes the landmark publications in this young field with an emphasis on the radiation responses of CSCs. The existence of CSCs in solid cancers place restrictions on the interpretation of many radiobiological observations, while explaining others. The fact that these cells may be a relatively quiescent subpopulation that are metabolically distinct from the other cells in the tumor has implications for both imaging and therapy of cancer. This is particularly true for biological targeting of cancer for enhanced radiotherapeutic benefit, which must consider whether the unique properties of this subpopulation allow it to avoid such therapies.
最近的实验证据表明,许多实体癌具有包含癌症干细胞(CSCs)亚群的分层组织结构。现在,前瞻性识别CSCs的能力使得测试CSCs对放射治疗等治疗方式的反应成为可能。初步研究发现,胶质瘤和乳腺癌中的CSCs对电离辐射相对耐药,并且已经探索了这种耐药背后的可能机制。这篇综述总结了这个新兴领域的标志性出版物,重点是CSCs的辐射反应。实体癌中CSCs的存在对许多放射生物学观察结果的解释产生了限制,同时也解释了其他一些观察结果。这些细胞可能是一个相对静止的亚群,在代谢上与肿瘤中的其他细胞不同,这一事实对癌症的成像和治疗都有影响。对于增强放射治疗益处的癌症生物靶向治疗来说尤其如此,这必须考虑这个亚群的独特特性是否使其能够避免此类治疗。